Novo investors call for dealmaking and new drugs

According to a report by Financial Times… Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday complete report is on link below. Source: https://www.ft.com/content/e560fd8c-5cc2-4743-90eb-eab71b899ce6?syn-25a6b1a6=1